Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors

Clinical trial NCT02225002 · COMPLETED

Trial details

NCT number: NCT02225002
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2004-01-01
Primary completion: 2006-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.